SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415015-07-000008
Filing Date
2007-10-15
Accepted
2007-10-15 16:19:09
Documents
2
Period of Report
2007-10-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 1539
2 bopoa.htm EX-24 120
  Complete submission text file 0001415015-07-000008.txt   3477
Mailing Address 550 HILLS DRIVE DRIVE BEDMINSTER NJ 07921
Business Address 550 HILLS DRIVE DRIVE BEDMINSTER NJ 07921 (908) 450-5300
NPS PHARMACEUTICALS INC (Issuer) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 550 HILLS DRIVE 3RD FLOOR BEDMINSTER NJ 07921
Business Address 908-450-5300
O'CALLAGHAN BRIAN (Reporting) CIK: 0001415015 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-23272 | Film No.: 071172171